The relationship between cannabis and Attention Deficit-Hyperactivity Disorder (ADHD) is complex and multifaceted. ADHD is a condition that manifests through a variety of symptoms, and cannabis may interact with these symptoms in different ways, potentially alleviating some while exacerbating others. The cannabis plant itself is intricate, containing over 500 biologically active components, adding to the complexity of understanding its effects on ADHD.
Cannabis has been found to have different effects on various ADHD symptoms. For instance, it might help reduce hyperactivity but negatively impact attention span. There is clinical and anecdotal evidence suggesting a growing perception of marijuana’s therapeutic benefits for ADHD. Nonetheless, the lack of extensive research on cannabis use in relation to ADHD makes it challenging to ascertain the potential long-term impacts.
Furthermore, long-term cannabis usage has been associated with a decline in IQ, as well as deficits in learning and processing speed, particularly when compared to individuals who have not used cannabis. This suggests that frequent cannabis use could potentially contribute to cognitive impairment.
People also utilize both marijuana and Ritalin (methylphenidate), for medicinal and recreational purposes, even though these might not be their intended uses. Ritalin is commonly prescribed for ADHD to help increase focus and decrease restlessness. Tetrahydrocannabinol (THC), the main active ingredient in marijuana, has a different set of effects.
On the non-drug treatment side, Cognitive Behavioral Therapy (CBT) has proven to be a widely used and effective approach for managing ADHD. CBT helps individuals change negative thought patterns, fostering positive and healthier ways of thinking, which can subsequently alter feelings and behaviors.
While cannabis does contain cannabidiol (CBD), which may help alleviate anxiety, it is essential to acknowledge that marijuana can also result in short-term cognitive and psychomotor impairments. Furthermore, it is critical to consider the risks associated with cannabis use, especially for individuals over the age of 55.
The cannabis plant also includes other cannabinoids like CBG (cannabigerol), which is marketed for its potential to alleviate various conditions. However, most of the studies conducted on CBG have been on animals, and further research is needed to understand its effects on humans.
Given all these factors, it is clear that the relationship between cannabis and ADHD is intricate, and more research is required to fully understand the long-term implications and potential therapeutic benefits of cannabis for managing ADHD.
University of Washington
University of Washington
Kaplan Lab at WWU
Harvard Health
Go Ask Alice!
Harvard Health
Harvard Health
Stanford University School of Medicine
Harvard Health
Harvard Health
